https://link.springer.com/article/10.1186/s41100-019-0246-3?error=cookies_not_supported&code=d65f8bff-0092-4885-ba66-c274383dae72
Constipation in chronic kidney disease: it is time to reconsider | Renal Replacement Therapy |...
Dec 12, 2019 - Constipation is highly prevalent in patients with chronic kidney disease (CKD) and is primarily characterized by decreased intestinal motility. This chroni
chronic kidney diseasetime
https://www.grandviewresearch.com/industry-analysis/us-continuous-renal-replacement-therapy-market-report
U.S. Continuous Renal Replacement Therapy Market Report, 2028
The U.S. continuous renal replacement therapy market size was valued at USD 601.7 million in 2020 and is expected to expand at a compound annual growth rate...
renal replacement therapyu
https://www.bioworld.com/articles/727065-nephrodites-holly-renal-replacement-named-breakthrough-device?v=preview
Nephrodite's Holly renal replacement named breakthrough device | BioWorld
Nephrodite Inc.'s Holly, an implantable, continuous renal replacement system, received U.S. FDA breakthrough device designation as a novel and potentially...
renal replacementhollynamed